Insights Podcasts Video ClinEco SCOPE Events About

Stay Connected to Clinical Research—All Year Long


SCOPE 365 is the year-round digital extension of SCOPE, bringing clinical research professionals continuous access to insights, live virtual meetups, expert interviews, and premium intelligence products. It’s a centralized hub designed to help sponsors, CROs, sites, and solution providers stay on the pulse of the industry, elevate thought leadership, and maintain momentum between SCOPE’s global conferences.

Get monthly SCOPE 365 insights in your inbox.
Insights from SCOPE

  • AI Digital Twins: Promise and Practical Limits in Clinical Trial Design

    Insights from SCOPE | The concept of a “digital twin” has moved from engineering into healthcare. In clinical research, an AI-based digital twin refers to a computational model that simulates how an individual patient might respond under different treatment scenarios. The promise is compelling. Yet digital twins are not a universal solution. Understanding both their potential and their limits is essential.

    Apr 7, 2026

  • From Pilot to Production: What It Really Takes to Deploy AI in Regulated Clinical Trials

    Insights from SCOPE | Artificial intelligence (AI) has moved well beyond the proof-of-concept phase in clinical research. Most large sponsors and CROs have experimented with predictive models, generative drafting tools, or automation workflows. Many have demonstrated measurable gains in efficiency within controlled environments. The real test, however, begins when AI systems move from pilot to production. In a regulated, global clinical trial environment, production does not simply mean scaling usage. It means operating reliably, audibly, and sustainably under scrutiny. The transition is not primarily a technical challenge. It is an operational one.

    Apr 2, 2026

  • Reverse Translation: Why Completed Trials Should Inform Future Design

    Insights from SCOPE | We all know, clinical research generates enormous volumes of data. And these volumes continue to grow. Every completed study contains detailed information on endpoints, eligibility criteria, enrollment performance, adverse events, dosing strategies, and operational outcomes. Yet once a trial closes and regulatory submissions are complete, much of that data becomes archival. It sits in repositories. It is referenced occasionally. It is rarely treated as an active design asset. This is beginning to change. Reverse translation, the practice of feeding insights from completed clinical trials back into earlier stages of development, offers a powerful opportunity to improve future study design.

    Mar 31, 2026

  • Long Screening Visits, Short Patience: Rethinking the Study Start Experience

    Insights from SCOPE | The first study visit sets the tone for everything that follows. For patients, screening is their introduction to clinical research. It is where expectations are formed, trust is built, and burden becomes real. For sites, it is often one of the most resource-intensive moments in the trial lifecycle. Yet screening visits have steadily grown longer and more complex. Additional laboratory panels, imaging requirements, multiple questionnaires, device training sessions, and layered consent discussions can turn what was once a straightforward evaluation into a multi-hour commitment. In some studies, screening stretches across multiple visits over several weeks. The impact is rarely neutral.

    Mar 26, 2026

SCOPE X

Webinar: The Biospecimen Management Crisis at Sites and Beyond

SCOPE 365 LinkedIn Group

SCOPE 365 Media Kit

Clinical Research News Online

Latest Podcasts and Videos


Listen Now »

View Episodes »

What You’ll Find in SCOPE 365

SCOPE of Things Podcast

SCOPE of Things

The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News Senior Writer, Deborah Borfitz, welcomes guests in the field.
View Episodes

Voices of SCOPE

Voices of SCOPE

Voices of SCOPE brings you unfiltered conversations with the people driving change in clinical research. These straight-talk interviews spotlight real lessons, fresh ideas, and practical innovations from leaders across pharma, biotech, tech, and patient advocacy.
View Episodes

SCOPE Summaries

SCOPE Summaries

Concise, accurate summaries of key presentations from SCOPE Summit U.S., SCOPE Europe, and SCOPE X, designed to help you quickly absorb what matters most.
View Summaries

Other Upcoming SCOPE Events

SCOPE Summit Orlando

SCOPE Summit
Orlando

REGISTER NOW
SCOPE Summit Europe

SCOPE Summit Europe
Barcelona, Spain

REGISTER NOW
SCOPE X Boston

SCOPE X
Boston

REGISTER NOW